Recruiting studies: Recipients Of Allogeneic Stem Cell Transplantation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Phase 2 · 1 location(s) · Loyola University · NCT05554068 Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.
Phase 4 · 12 location(s) · WeiShi · NCT07569653 Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04099082 Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
Phase 2 · 5 location(s) · Vastra Gotaland Region · NCT06793410 Shingrix In Recipients of Allogeneic Transplants
Phase 2 · 1 location(s) · University of Colorado, Denver · NCT05775718 A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of He
Phase 2 · 1 location(s) · University Hospital, Basel, Switzerland · NCT02007356 A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Phase 1 · 12 location(s) · Orca Biosystems, Inc. · NCT03802695 Monitoring of Measles-specific Immune Status in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients
NA · 1 location(s) · Hospices Civils de Lyon · NCT05947864

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.